Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Daichi Tamura"'
Autor:
Yuta Goto, Daichi Tamura, Tomohiko Matsuura, Ei Shiomi, Daiki Ikarashi, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Wataru Obara
Publikováno v:
IJU Case Reports, Vol 7, Iss 4, Pp 301-304 (2024)
Introduction Secondary eosinophilia due to solid tumors is a rare case. This is the first study to report secondary eosinophilia due to renal cancer in a patient on dialysis. Case presentation A 70‐year‐old man, on long‐term hemodialysis was in
Externí odkaz:
https://doaj.org/article/638cf1c4314c4fa6a4e10e8e4bf288d8
Autor:
Masakazu Abe, Ryo Takata, Daiki Ikarashi, Kie Sekiguchi, Daichi Tamura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Takashi Ujiie, Wataru Obara
Publikováno v:
Prostate International, Vol 11, Iss 4, Pp 212-217 (2023)
Background: Prostate cancer in the anterior region may be missed on a transrectal systematic biopsy (SBx). Therefore, this study aimed to evaluate the performance of magnetic resonance imaging-transrectal ultrasound (MRI-TRUS) fusion targeted biopsy
Externí odkaz:
https://doaj.org/article/24d86e8111e840eb85081e712413c358
Autor:
Yoichiro Kato, Daiki Ikarashi, Daichi Kikuchi, Misato Takayama, Seiko Kanzaki, Akito Ito, Daichi Tamura, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Wataru Obara
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective To investigate if the use of therapeutic agents for dysuria is a risk factor for the primary recurrence of non-muscle invasive bladder cancer (NMIBC). Methods First, patients with NMIBC were divided into two groups: the non-recurrence group
Externí odkaz:
https://doaj.org/article/dd1a7b4912c84f1e9c5c28e14ce4db62
Autor:
Daiki Ikarashi, Shigehisa Kitano, Kazuyuki Ishida, Tetsuya Nakatsura, Hitoshi Shimodate, Takashi Tsuyukubo, Daichi Tamura, Renpei Kato, Tamotsu Sugai, Wataru Obara
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Treatment options as second-line therapy for advanced ureteral carcinoma are limited, and patients experiencing recurrence after first-line cisplatin-based chemotherapy have a poor prognosis. Recently, the programmed death-1 (PD-1) inhibitor pembroli
Externí odkaz:
https://doaj.org/article/435f37f9064c4717b015cd17a6c2d414
Autor:
Tomohiko Matsuura, Ayato Ito, Mariko Moriguchi, Daiki Ikarashi, Daichi Tamura, Renpei Kato, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Takaya Abe, Wataru Obara
Publikováno v:
Journal of Endourology. 36:641-646
Autor:
Daichi Tamura, Masakazu Abe, Daiki Ikarashi, Renpei Kato, Yoichiro Kato, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Yutaka Suzuki, Hidewaki Nakagawa, Satoshi Nishizuka, Wataru Obara
Publikováno v:
Journal of Urology. 209
Autor:
Mitsugu Kanehira, Daichi Tamura, Tomohiko Matsuura, Shigekatsu Maekawa, Renpei Kato, Yoichiro Kato, Ryo Takata, Wataru Obara
Publikováno v:
Asian Journal of Endoscopic Surgery. 15:700-704
Publikováno v:
Journal of Rural Medicine. 17:248-254
Autor:
Daichi Tamura, Masakazu Abe, Renpei Kato, Yoichiro Kato, Shigekatsu Maekawa, Mitsugu Kanehira, Ryo Takata, Yutaka Suzuki, Hidewaki Nakagawa, Satoshi Nishizuka, Wataru Obara
Publikováno v:
Journal of Urology. 207
Publikováno v:
Journal of Japan Society of Civil Engineers, Ser. F1 (Tunnel Engineering). 77:92-97